Straumann Holding AG Total Non-Operating Income/Expense 2012-2024 | SAUHY

Straumann Holding AG annual/quarterly total non-operating income/expense history and growth rate from 2012 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
  • Straumann Holding AG total non-operating income/expense for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Straumann Holding AG total non-operating income/expense for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Straumann Holding AG annual total non-operating income/expense for 2024 was $-0.047B, a 35.34% decline from 2023.
  • Straumann Holding AG annual total non-operating income/expense for 2023 was $-0.073B, a 88.18% increase from 2022.
  • Straumann Holding AG annual total non-operating income/expense for 2022 was $-0.039B, a 45.77% decline from 2021.
Straumann Holding AG Annual Total Non-Operating Income/Expense
(Millions of US $)
2024 $-47
2023 $-73
2022 $-39
2021 $-71
2020 $-45
2019 $-22
2018 $-17
2017 $40
2016 $-5
2015 $-96
2014 $32
2013 $7
2012 $-4
2011 $0
Straumann Holding AG Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2024-12-31
2024-06-30
2023-12-31
2022-12-31
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2018-12-31
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2014-12-31
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.418B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $86.909B 20.95
Becton Dickinson (BDX) United States $47.926B 11.87
Cardinal Health (CAH) United States $35.377B 18.53
Labcorp (LH) United States $20.568B 16.68
Cooper (COO) United States $16.452B 21.82
West Pharmaceutical Services (WST) United States $15.307B 32.09
Align Technology (ALGN) United States $13.184B 26.17
Henry Schein (HSIC) United States $8.355B 14.33
Merit Medical Systems (MMSI) United States $5.664B 27.38
DENTSPLY SIRONA (XRAY) United States $3.151B 9.41
CONMED (CNMD) United States $1.766B 13.21
STAAR Surgical (STAA) United States $0.962B 0.00
Lifevantage (LFVN) United States $0.154B 15.94
Pro-Dex (PDEX) United States $0.144B 15.82